Evaluating progress of obesity prevention: What should we measure?
Tuesday, November 5, 2013
: 10:50 a.m. - 11:10 a.m.
The Committee on Evaluating Progress of Obesity Prevention was charged with identifying and developing indicators that could be used at the national and community levels for measuring progress in obesity prevention. Indicators of progress were drawn from the 2012 IOM report, Accelerating Progress in Obesity Prevention (APOP), as well as other currently and widely used indicator sources. In alignment with APOP, the focus was on indicators related to policy and environmental change, eating and physical activity behaviors, and weight outcomes and obesity, viewed through the lens of systems theory and elimination of health disparities. Indicators for both process (to evaluate intervention activities) and outcomes (to evaluate the impact of intervention activities) will be discussed. The presentation will highlight the benefits of using consistent and actionable measurement of progress in obesity prevention across settings and over time that could support both national and local evaluation efforts as well as facilitate comparisons across communities to document the relative effectiveness of policies and programs and to support efforts to identify what works where'.
Conduct evaluation related to programs, research, and other areas of practice
Public health or related research
Systems thinking models (conceptual and theoretical models), applications related to public health
Explain the criteria and methods used to identify indicators for evaluating obesity prevention efforts.
Discuss the benefits of using indicators across multiple interventions and settings.
Keyword(s): Obesity, Evaluation
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am a Member of the IOM Committee on Evaluating Progress of Obesity Prevention Efforts.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.